There are currently clinical trials underway to assess the effectiveness of these GLP-1 receptor agonists in the treatment of substance and alcohol use disorders
Schedule a consultation and let our board-certified physicians help determine the best treatment plan for your health goals
Semaglutide is an FDA-approved injectable drug that is used to treat type 2 diabetes mellitus
Transport of oxidized glutathione into barley vacuolesEvidence for the involvement of the glutathione-S-conjugate atpase
Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved and removed from the FDAs shortage list, see our prior blog GLP-1 Drugs: FDA Removes Lillys Zepbound and Mounjaro (tirzepatide injection) from its Drug Shortage List, on October 8, 2024, the Outsourcing Facilities Association (OFA) a trade association representing FDA-registered 503B outsourcing facilities filed a lawsuit against the FDA relating to the agencys removal of tirzepatide, from the FDAs drug shortage list
Its hepatoprotective action may occur by cytokine-mediated mechanisms as well as GSH replenishment (21)